Desmopressin (Nocdurna and Noctiva) for Nocturnal Polyuria

Date: March 25, 2019
Issue #: 
1568Summary: 
The FDA has approved a sublingual tablet (Nocdurna–
Ferring) and a nasal spray (Noctiva– Avadel) formulation
of desmopressin acetate for treatment of nocturia due to
nocturnal polyuria in adults who wake up ≥2 times per
night to void.Nocdurna andNoctiva are the first two
products to be approved in the US for this indication.
Higher-strength nasal spray and oral tablet formulations
of desmopressin (DDAVP, and others) have been available
for years for treatment of diabetes insipidus and primary
nocturnal enuresis (bedwetting in children). In 2007, the
indication for primary nocturnal enuresis was removed
from the labels of the nasal spray formulations because
their use resulted in 61 cases of hyponatremia-related
seizures, 2 of which resulted in death.

Source: The Medical Letter - March 15, 2019 Category: Drugs & Pharmacology Authors: admin Source Type: research